lactose has been researched along with Liver Dysfunction in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Cuyper, M; Dresselaers, T; Himmelreich, U; Hodenius, M; Ketkar-Atre, A; Lambrichts, I; Mannaerts, I; Ni, Y; Struys, T; Van Grunsven, LA | 1 |
| Joung, JY; Kim, SH; Kim, Y; Lee, HA; Lee, KW; Oh, NS; Shin, YK; Young Lee, J | 1 |
| Diakur, J; Huang, G; Wiebe, LI; Xu, Z | 1 |
| Deelder, AM; Hokke, CH; Jacobs, W; Van de Vijver, KK; Van Marck, EA | 1 |
| Aggarwal, RK; Dhatt, PS; Mehta, HC; Saini, AS; Singh, H; Sood, SC | 1 |
| Akaike, T; Shibuya, I; Watanabe, Y | 1 |
| Sasaki, Y | 1 |
| Drasar, BS; Hill, MJ | 1 |
| Buhler, DR; Carpenter, HM; Harvey, MJ | 1 |
| Langdon, DE; Welsh, JD | 1 |
| Bircher, J; Haemmerli, UP; Williams, R | 1 |
| Hayashi, T | 1 |
| Bernard, C; Drevet, J | 1 |
| Decoulx, M; Linquette, M | 1 |
1 trial(s) available for lactose and Liver Dysfunction
| Article | Year |
|---|---|
Lactulose in the treatment of portal-systemic encephalopathy. Report of a symposium.
Topics: Adult; Animals; Brain Diseases; Child; Dogs; Electroencephalography; Fructose; Hepatic Encephalopathy; Humans; Intestinal Absorption; Lactose; Liver Cirrhosis; Liver Diseases; Placebos; Portacaval Shunt, Surgical; Portal System; Sorbitol | 1970 |
14 other study(ies) available for lactose and Liver Dysfunction
| Article | Year |
|---|---|
In vivo hepatocyte MR imaging using lactose functionalized magnetoliposomes.
Topics: Animals; Anions; Asialoglycoprotein Receptor; Cells, Cultured; Contrast Media; Ferric Compounds; Hepatocytes; Lactose; Liposomes; Liver; Liver Diseases; Magnetic Resonance Imaging; Male; Mice | 2014 |
Chemical characteristics and enhanced hepatoprotective activities of Maillard reaction products derived from milk protein-sugar system.
Topics: Animals; Antioxidants; Caseins; Electrophoresis, Polyacrylamide Gel; Glucose; Hep G2 Cells; Hot Temperature; Humans; Lactose; Liver Diseases; Maillard Reaction; Mass Spectrometry; Milk Proteins; Oxidation-Reduction; Whey Proteins | 2016 |
Asialoglycoprotein receptor-targeted superparamagnetic iron oxide nanoparticles.
Topics: Acetylation; Asialoglycoprotein Receptor; Cell Line; Cell Line, Tumor; Cell Separation; Cell Survival; Ferric Compounds; Galactose; Hepatocytes; Humans; Lactose; Light; Liver Diseases; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Nanoparticles; Particle Size; Scattering, Radiation | 2008 |
LacdiNAc- and LacNAc-containing glycans induce granulomas in an in vivo model for schistosome egg-induced hepatic granuloma formation.
Topics: Acetylation; Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Extracellular Matrix Proteins; Galectin 3; Granuloma; Immunohistochemistry; Lactose; Liver Diseases; Male; Mice; Mice, Inbred BALB C; Ovum; Polysaccharides; Schistosoma | 2006 |
Disaccharide intolerence and Indian childhood cirrhosis. IV. Relationship of melituria to lactose administration.
Topics: Carbohydrate Metabolism, Inborn Errors; Child, Preschool; Disaccharides; Humans; India; Infant; Lactose; Lactose Intolerance; Liver Cirrhosis; Liver Diseases | 1982 |
Design of a temporally and spatially controlled drug delivery system for the treatment of liver diseases in mice.
Topics: Animals; Asparagine; Capsules; Caspase Inhibitors; Delayed-Action Preparations; Drug Delivery Systems; Enzyme Inhibitors; Lactose; Liver; Liver Diseases; Mice; Microspheres; Polystyrenes | 2000 |
Tracers excreted as Gas: 14C breath analysis.
Topics: Animals; Bile Acids and Salts; Breath Tests; Carbon Dioxide; Carbon Radioisotopes; Ethnicity; Glycocholic Acid; Humans; Ileum; Intestinal Diseases; Lactose; Liver Diseases; Malabsorption Syndromes; Metabolic Diseases; Rats | 1978 |
The normal colonic bacterial flora.
Topics: Ammonia; Bacteria; Bacteroides; Bile Acids and Salts; Carcinogens; Chloramphenicol; Clostridium; Colon; Colonic Neoplasms; Diet; Escherichia coli; Eubacterium; Feces; Glucuronates; Glucuronidase; Glycosides; Hepatic Encephalopathy; Humans; Hydrolysis; Lactobacillus; Lactose; Liver Diseases; Streptococcus; Urea | 1975 |
The effect of tetrachlorohydroquinone on hexachlorobenzene-induced porphyria in Japanese quail.
Topics: 5-Aminolevulinate Synthetase; Administration, Oral; Animals; Body Weight; Chemical and Drug Induced Liver Injury; Chlorobenzenes; Coturnix; Drug Interactions; Female; Hexachlorobenzene; Hydroquinones; Lactose; Liver; Liver Diseases; Organ Size; Porphyrias; Porphyrins | 1985 |
Treatment of chronic hepatic encephalopathy.
Topics: Colostomy; Diet Therapy; Disaccharides; Humans; Ileostomy; Lactose; Liver Cirrhosis; Liver Diseases; Mental Disorders; Middle Aged; Neomycin; Nervous System Diseases | 1970 |
Lactose to treat hepatic encephalopathy in patient with lactose malabsorption.
Topics: Administration, Oral; Central Nervous System Diseases; Female; Humans; Lactose; Lactose Intolerance; Liver Diseases; Mental Disorders; Nervous System Diseases | 1972 |
[Heart disease and glucose].
Topics: Electrocardiography; Glucose; Heart Diseases; Humans; Lactose; Liver Diseases; Myocardium; Oxygen; Pyruvates | 1968 |
[Therapeutic trial of EU 2200].
Topics: Adult; Aged; Citrates; Drug Synergism; Female; Humans; Hypoxanthines; Lactose; Liver Diseases; Male; Middle Aged; Sorbitol | 1968 |
[Clinical experimentation with a new hepatotropic agent, EU 2200].
Topics: Adult; Aged; Citrates; Female; Gastrointestinal Diseases; Humans; Hypoxanthines; Lactose; Liver Diseases; Male; Middle Aged; Sorbitol | 1966 |